filmov
tv
Psychedelics and Plasticity-Promoting Neurotherapeutics - UC Davis Psychedelic Summit 2023
Показать описание
David Olson, Ph.D.,
Director of the
UC Davis Institute for Psychedelics
and Neurotherapeutics, discusses “Psychedelics and Plasticity-Promoting Neurotherapeutics." The lecture was recorded March 23, 2023, at the Psychedelic Summit on the UC Davis Health campus in Sacramento, California.
The UC Davis Psychedelic Summit brought together national experts to explore what the rapidly evolving field of psychedelics and neurotherapeutics may mean for neuropsychiatric and neurodegenerative diseases. These new treatment types may hold promise for anxiety, depression, substance use, obsessive-compulsive and post-traumatic stress disorders, among others. The event was hosted by the UC Davis Department of Psychiatry and Behavioral Sciences, the UC Davis Institute for Psychedelics and Neurotherapeutics, and the UC Davis Behavioral Health Center for Excellence.
The information in this video was accurate as of the upload date, 5/13/23. For information purposes only. Consult your local medical authority for advice.
#Neurotherapeutics #psychedelic #ucdavis
Director of the
UC Davis Institute for Psychedelics
and Neurotherapeutics, discusses “Psychedelics and Plasticity-Promoting Neurotherapeutics." The lecture was recorded March 23, 2023, at the Psychedelic Summit on the UC Davis Health campus in Sacramento, California.
The UC Davis Psychedelic Summit brought together national experts to explore what the rapidly evolving field of psychedelics and neurotherapeutics may mean for neuropsychiatric and neurodegenerative diseases. These new treatment types may hold promise for anxiety, depression, substance use, obsessive-compulsive and post-traumatic stress disorders, among others. The event was hosted by the UC Davis Department of Psychiatry and Behavioral Sciences, the UC Davis Institute for Psychedelics and Neurotherapeutics, and the UC Davis Behavioral Health Center for Excellence.
The information in this video was accurate as of the upload date, 5/13/23. For information purposes only. Consult your local medical authority for advice.
#Neurotherapeutics #psychedelic #ucdavis
0:48:56
Psychedelics and Plasticity-Promoting Neurotherapeutics - UC Davis Psychedelic Summit 2023
0:24:20
Psychedelics Promote Brain Plasticity by Binding to TrkB receptors
0:01:01
Part 1: Why is neuroplasticity important? #psychedelic
0:51:17
Beyond Psychedelics: Augmenting Mood Enhancing Effects - UC Davis Psychedelic Summit 2023
0:51:16
The Cognitive Neuroscience of Psychedelic Drugs - UC Davis Psychedelic Summit 2023
0:05:58
Reorganizational psychedelic experiences, neuroplasticity, and their role in treating addiction
0:09:49
The Playdough of the Mind: How Psychedelics Boost Neuroplasticity
0:06:02
The Promise of Psychedelics in Medicine - UC Davis Psychedelic Summit 2023
0:09:54
Psychedelics Promote Neuritogenesis
0:37:51
Psychedelics Slip into Our Neurons - Breakthrough Study Finds
0:31:30
Psychedelics without the hallucinations: A new mental health treatment? with David E. Olson
0:00:55
Oprah and Dr. Griffiths Discuss Using Psychedelics in Medicine
0:20:25
DCC Insiders Tour: Where Excellence Gathers, Dr. David Olson
0:47:55
Non-Hallucinogenic Psychoplastogens | The Next Stage of the Psychedelic Revolution
0:02:06
How Ibogaine Promotes GDNF 'miracle grow for the brain'
0:01:01
Dr. Fleet Maull at the Psychedelic Science Conference 2023 #psychology
1:00:58
MINDSET Lecture Series: Charles D. Nichols, PhD
0:49:14
Probing and Rescuing Dysfunctional Brain Circuits in Depression - UC Davis Psychedelic Summit 2023
0:51:40
Improving Mental Health Through Chemistry and Neuroscience - David Olson
0:01:28
David Hellerstein on COMPASS’s Phase IIb trial: Psilocybin Therapy for TRD
0:04:17
Elements of Science - Neuroplasticity
0:27:37
Neuroplasticity, Metaplasticity, Psychedelics & Visual Impairments (Amblyopia)
0:01:28
Sub-hallucinogenic Doses of Psychedelics May Offer New Treatments for Depression, Related Disorders
1:29:20
Explorations in Interdisciplinary Psychedelic Research: Group Two
Комментарии